Oxford University Innovation Fund
Investor profile
Oxford University Innovation Fund has backed 4 European tech companies across 5 funding rounds between 2018 and 2025, joining rounds totalling €131M. Most active in Healthtech. Data as of Nov 2026.
Deals
5
distinct rounds
Companies
4
backed
Active span
2018–2025
8 yrs
Total round €
€131M
sum of rounds joined
Deals by year
distinct rounds / yearOxford University Innovation Fund — deals by year — interactive chart.
Data table
| Oxford University Innovation Fund — deals by year | |
|---|---|
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 2 |
Top sectors
by dealsOxford University Innovation Fund — top sectors — interactive chart.
Data table
| Oxford University Innovation Fund — top sectors | |
|---|---|
| Healthtech | 5 |
Stages
by dealsOxford University Innovation Fund — stages — interactive chart.
Data table
| Oxford University Innovation Fund — stages | |
|---|---|
| Seed | 2 |
| Series B | 2 |
| Other | 1 |
Countries
by dealsOxford University Innovation Fund — countries — interactive chart.
Data table
| Oxford University Innovation Fund — countries | |
|---|---|
| UK | 5 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| OMass Therapeutics | UK | 1 | €90M |
| Brainomix | UK | 2 | €27M |
| Scripta Therapeutics | UK | 1 | €10M |
| DaltonTx | UK | 1 | €4.6M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| OMass Therapeutics | Series B | €90M | 2022-04 |
| Brainomix | Series B | €19M | 2021-12 |
| Scripta Therapeutics | Seed | €10M | 2025-11 |
| Brainomix | Other | €8.0M | 2018-02 |
| DaltonTx | Seed | €4.6M | 2025-09 |